Relapse of infection in single and mixed trypanosome infections in rats after diminazene aceturate treatment by Tobias Nnia Egbe-Nwiyi et al.
255
VETERINARSKI ARHIV 76 (3), 255-262, 2006
* Contact address:
Dr. Tobias Nnia Egbe-Nwiyi, Department of Veterinary Pathology, University of Maiduguri, P.M.B. 1069, Maiduguri, Borno 




Relapse of infection in single and mixed trypanosome infections in 
rats after diminazene aceturate treatment
Tobias Nnia Egbe-Nwiyi1*, Ikechukwu Onyebuchi Igbokwe1, and Patrick 
Azubike Onyeyili2
1Department of Veterinary Pathology, University of Maiduguri, Maiduguri, Borno State, Nigeria
2Department of Veterinary Physiology and Pharmacology, University of Maiduguri, Maiduguri, Borno State, 
Nigeria
EGBE-NWIYI, T. N., I. O. IGBOKWE, P. A. ONYEYILI: Relapse of infection in 
single and mixed trypanosome infections in rats after diminazene aceturate treatment. 
Vet. arhiv 76, 255-262, 2006. 
ABSTRACT 
Four groups (A, B, C and D) of 10 rats in each group were used to investigate relapse of infection in single 
and mixed trypanosome infections. Groups A served as uninfected control, groups B and C were infected with 
Trypanosoma brucei (Wamba strain) and T. congolense (Federe strain), respectively, and group D was infected 
with both species (50% of each species in the infective inoculum). Each infected rat received 1×106 trypanosomes 
by intraperitoneal injection of the inoculum. On day 14 post-infection, when the parasitaemia had reached the 
peak, infected rats were treated with diminazene aceturate at a dose of 10.5 mg/kg as a single intraperitoneal 
injection. All rats were aparasitaemic after treatment until days 42 and 49 post-treatment, when relapse of T. 
brucei infection occurred in two rats in each of groups B and D, respectively. All effectively cured rats remained 
aparasitaemic until the end of experiment on day 91 post-treatment. In conclusion, only T. brucei relapsed in 
20% of treated cases in both single and mixed infections, whereas no relapse occurred in treated T. congolense 
infection, thus indicating that the interaction of T. brucei and T. congolense in mixed infections did not affect 
the curability of T. congolense infection.
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Introduction
Diminazene aceturate (Berenil) is one of the conventional trypanocides for treatment 
of African trypanosomosis. Resistance of trypanosomes to the drug has been reported 
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(ONYEYILI and EGWU, 1995). Although resistance to this drug was reported only with 
Trypanosoma brucei in Nigeria and Uganda, T. congolense resistance also occurred in 
Ethiopia and Zimbabwe (GEERTS and HOLMES, 1998). After treatment with the drug, 
relapse infections had occurred in T. brucei-infected (ONYEYILI and ONWUALU, 1991; 
EGBE-NWIYI and ANTIA, 1996) and T. congolense infected animals (BURUDI et al., 1994; 
MAMMAN et al., 1994 and 1995).
Natural mixed infections have been reported (JOSHUA and IGE, 1982; KALU et al., 
1991) although it is not known whether the interaction of the trypanosome species in 
mixed infections would affect sensitivity of each species to the drug. Multiple species 
relapse infections after treatment may occur in the field, but such information seems not 
to be presently available.
In the present study, relapse of infection after diminazene aceturate treatment was 
studied in single and mixed trypanosome (T. brucei and T. congolense) infections in rats.
Materials and methods
Experimental animals. Forty healthy adult albino rats of both sexes weighing between 
180-198g obtained from the Department of Pharmacology, University of Jos, Nigeria, 
were used for the study. They were housed in clean cages at room temperature (30-35 
0C) in a fly-proof house, fed commercial diets (ECWA Feeds Ltd. Jos, Nigeria) and water 
was offered ad libitum. The rats were screened for the presence of blood parasites using 
wet and Giemsa-stained thin blood films (COLES, 1980) prior to commencement of the 
experiment.
Trypanosomes. Trypanosoma brucei brucei (Wamba strain) and T. congolense (Federe 
strain) were obtained from the National Institute for Trypanosomosis Research (NITR), 
Vom, Nigeria. The organisms were maintained separately by serial passages in rats.
Trypanocidal treatment. Diminazene aceturate (Berenil®, Hoechst, Farbwerk AG, 
Frankfurt am Main, Germany) was diluted to 7% and given as a single intraperitoneal 
injection at a dose of 10.5 mg/kg to the infected rats.
Experimental design. Four groups (A-D) of 10 rats were used as follows: Group 
A comprised uninfected controls. Groups B and C were infected with T. brucei (1×106 
trypanosomes), and T. congolense (1×106 trypanosomes), respectively. Each rat in group D 
was infected with T. brucei (1×103 trypanosomes) and T. congolense (1×103 trypanosomes). 
The rats were infected with blood from previously infected donors after dilution with 
phosphate buffered saline solution (pH 7.4). Tail blood was used to determine packed cell 
volume (PCV) and the level of parasitaemia by the microhaematocrit centrifuge method 
and haemocytometer method, respectively (COLES, 1980). Infected rats were treated with 
diminazene aceturate on day 14 post-infection (pi). Thereafter, they were monitored for 
relapse of infection and full recovery from anaemia after treatment.
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Statistical analysis. Obtained data were summarized as means ± standard deviations and 
analysis of variance (ANOVA). Student’s t-test was used to compare means (CHATFIELD, 
1983).
Results
The mean prepatent periods in groups B, C and D were 5.3 ± 0.8, 7.3 ± 0.7 and 4.5 
± 0.5 days, respectively. The prepatent period in T. congolense infected rats was longer 
(P<0.05) than in T. brucei infected rats and rats with mixed infections. Those with mixed 
infections had a shorter prepatent period. The level of parasitaemia increased progressively 
(Fig. 1a) and was significantly (P<0.05) higher in the rats with mixed infections (Group 
D) than those with single infections (Groups B and C). The infection caused a comparable 
decrease in PCV in groups B, C and D on day 14 pi (Fig. 1b).
After the trypanocidal treatment on day 14 pi, the PCV began to recover. However, 
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there was a relapse of infection due to T. brucei in groups B and D on days 42 and 49 
post-treatment (pt), respectively. Two rats in each of those groups showed relapse. In the 
effectively cured rats, PCV continued to recover until day 91 pt (end of experiment) when 
the mean PCV value of the groups were almost comparable with the pre-infection mean 
PCV (Fig. 1c). At this time, the relapsed cases had a mean PCV of 20.8 ± 0.4%, compared 
to 44.6 ± 11.3% at day 14 pi.
Fig. 1a. Mean parasitaemia of rats infected with T. brucei (group B), T. congolense (group C) and 
a combination of T. brucei and T. congolense (group D)
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Fig. 1b and c. Mean packed cell volume (PCV%) of control rats (group A) and rats infected with 
T. brucei (group B), T. congolense (group C) and a combination of T. brucei and T. congolense 
(group D) and responses of the various groups (B, C and D) to treatment with diminazene 
aceturate
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Discussion
Each infected rat in all groups received the same number of trypanosomes in the 
infective inoculum. This was to eliminate the possible influence of infective dose on the 
prepatent period and subsequent parasitaemia  (MURRAY and DEXTER, 1988). Prepatent 
periods were shorter in T. brucei than T. congolense infections, as earlier reported 
(IGBOKWE and NWOSU, 1997).  Thus, T. brucei would appear in circulation earlier than 
T. congolense in mixed infections. The mixed infections showed higher parasitaemia than 
the single infections, an observation supported by reports that natural mixed infections 
were often more severe (LOSOS, 1986).
When the infections were treated at the peak of parasitaemia (14 days pi) with 
diminazene aceturate at a dose of 10.5mg/kg, T. brucei was cured in only 80% of cases in 
the single and mixed infections, while T. congolense was cured in all cases. Cured animals 
were observed for 91 days, beyond the 60 days recommended for evaluation of drug 
sensitivity in trypanosome chemotherapy (GEERTS and HOLMES, 1998). It appeared that 
T. congolense strain was not resistant to diminazene aceturate. This is consistent with the 
lack of reports of diminazene aceturate -resistant T. congolense in Nigeria (GEERTS and 
HOLMES, 1998). However, relapse of T. brucei infection occurred in the same proportion 
in groups with single and mixed infections, and similar relapses has been reported by 
other authors in only single infections (ONYEYILI and ONWUALU, 1991; EGBE-NWIYI 
and ANTIA, 1996).
After treatment the animals showed aparasitaemia and apparent gradual recovery of 
PCV, but by days 42-49 pt, the trypanosomes broke into circulation again in cases with 
therapeutic failure. The subsequent parasitaemic relapse prevented the recovery of PCV 
in the uncured cases, but PCV fully recovered in cured cases. The relapse of T. brucei 
infection might have originated from privileged sites inaccessible to the drug (MAMMAN 
et al., 1994; ONYEYILI and EGWU, 1995) where the trypanosomes would not have been 
exposed to curative concentrations of drug. Since T. brucei was more tissue-invasive than 
T. congolense it was speculated that tissue damage by T. brucei would have enhanced 
access of T. congolense into drug-inaccessible sites to encourage its subsequent relapse. The 
interaction of T. brucei and T. congolense in the mixed infections did not seem to influence 
the drug sensitivity of T. congolense. The trypanosomes from the relapse infection in rats 
with mixed infections were studied in subsequent passages in naïve rats. No T. congolense 
sub-population was identified (EGBE-NWIYI, 2002).
Although 3.5mg/kg is the recommended curative dose of diminazene aceturate in 
trypanosome infections (CUNNINGHAM and GRAINNAGE, 1965), higher doses (7-10.5 
mg/kg) have been used (KAGGWA et al., 1988; ONYEYILI and ONWUALU, 1991; KALU, 
1995; EGBE-NWIYI and ANTIA, 1996) for anticipated improved efficacy. Since underdosing 
enhances the chance of development of drug resistance (GEERTS and HOLMES, 1998), 
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increasing dosage appears to be a corollary for avoidance of such drug resistance. Relapse 
of infection occurred at the higher dose used in this study to buttress the recommendation 
that higher doses should not be used to eliminate relapse of infection (EGBE-NWIYI et al., 
2003).
In conclusion, treatment of single and mixed infections of T. brucei and T. congolense 
in rats with diminazene aceturate at 10.5mg/kg led to relapse of infection of T. brucei (20% 
of cases) in both single and mixed infections, although T. congolense infected animals were 
effectively cured in all cases. Therefore, interaction of both species in mixed infections 
did not encourage relapse of T. congolense infection, nor did it affect the frequency of 
relapse of T. brucei infection.
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SAŽETAK
Istraživanje je provedeno na 4 skupine (A, B, C, D) po 10 štakora invadiranih jednom ili dvjema vrstama 
tripanosoma. Skupina A predstavljala je neinvadiranu kontrolu. Skupina B bila je invadirana vrstom Trypanosoma 
brucei (soj Wamba), a skupina C vrstom Trypanosoma congolense (soj Federe). Skupina D invadirana je objema 
vrstama (50% svake vrste u inokulu). Svaki štakor invadiran je s 1x106 tripanosoma ubrizgavanjem u peritonejsku 
šupljinu. Četrnaestoga dana nakon invazije, na vrhuncu parazitemije, štakori su liječeni ubrizgavanjem 10,5 
mg/kg diminazen-aceturata. Prisutnost tripanosoma u krvi nije bila ustanovljena sve do 42. i 49. dana nakon 
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liječenja, kada je u dvaju štakora iz skupina B i D ustanovljena vrsta T. brucei. Parazitemija nije bila dokazana 
u ostalih štakora sve do završetka pokusa 91. dana nakon invazije. U zaključku se navodi da se invazija vrstom 
T. brucei povratila u 20% invadiranih štakora. Povratak invazije nije zabilježen u skupini invadiranoj vrstom T. 
congolense, što govori da međusobno djelovanje vrsta T. brucei i T. congolense u mješovitoj invaziji ne utječe 
na izlječenje invazije praživotinjom T. congolense.
Ključne riječi: kemoterapija, Trypanosoma brucei, Trypanosoma congolense, diminazen-aceturat, mješovita 
invazija, štakori
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